Originalpublikationen
Hachulla E, Clerson P, Airò P, Cuomo G, Allanore Y, Caramaschi P, Rosato E, Carreira PE, Riccieri V, Sarraco M, Denton CP, Riemekasten G, Pozzi MR, Zeni S, Mihai CM, Ullman S, Distler O, Rednic S, Smith V, Walker UA, Matucci-Cerinic M, Müller-Ladner U, Launay D; EUSTAR co-workers. Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population. Rheumatology (Oxford). 2015 Jul;54(7):1262-9. doi: 10.1093/rheumatology/keu450. Epub 2015 Jan 17.
Humrich JY, von Spee-Mayer C, Siegert E, Alexander T, Hiepe F, Radbruch A, Burmester GR, Riemekasten G.Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE. Ann Rheum Dis. 2015 Apr;74(4):791-2. doi: 10.1136/annrheumdis-2014-206506. Epub 2015 Jan 21.
Humrich JY, Kamradt T, Riemekasten G. [Regulatory T cells and rheumatic diseases].[Article in German]. Z Rheumatol. 2015 Feb;74(1):26-32. doi: 10.1007/s00393-014-1446-4.
Aringer M, Müller-Ladner U, Burkhardt H, Distler JH, Distler O, Graninger WB, Günther C, Hunzelmann N, Kiener H, Sticherling M, Sunderkötter C, Walker UA, Riemekasten G.[Common German language nomenclature for systemic sclerosis]. [Article in German] Z Rheumatol. 2015 Mar;74(2):100-3. doi: 10.1007/s00393-014-1550-5.
Becker MO, Riemekasten G. Reply: vascular receptor autoantibodies in pulmonary arterial hypertension.Am J Respir Crit Care Med. 2015 Mar 1;191(5):602-3. doi: 10.1164/rccm.201412-2322LE.
Kopetschke K, Klocke J, Grießbach AS, Humrich JY, Biesen R, Dragun D, Burmester GR, Enghard P, Riemekasten G. The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers. Arthritis Res Ther. 2015 Apr 3;17:94. doi: 10.1186/s13075-015-0600-y.
Schüler S, Wolters S, Pitann S, Kabelitz D, Lamprecht P. Increased co-expression of the natural killer cell receptor NKG2D and further natural killer cell receptors on CD4⁺ T cells in granulomatosis with polyangiitis. Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-183-4. Epub 2015 May 26
Park SH, Chen WC, Durmus N, Bleck B, Reibman J, Riemekasten G, Grunig G.The Effects of Antigen-Specific IgG1 Antibody for the Pulmonary-Hypertension-Phenotype and B Cells for Inflammation in Mice Exposed to Antigen and Fine Particles from Air Pollution. PLoS One. 2015 Jun 16;10(6):e0129910. doi: 10.1371/journal.pone.0129910. eCollection 2015.
Schüler S, Wolters S, Pitann S, Kabelitz D, Lamprecht P. Increased co-expression of the natural killer cell receptor NKG2D and further natural killer cell receptors on CD4⁺ T cells in granulomatosis with polyangiitis. Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-183-4. Epub 2015 May 26.
Avouac J, Riemekasten G, Meune C, Ruiz B, Kahan A, Allanore Y. J Rheumatol. 2015 Oct;42(10):1801-7. doi: 10.3899/jrheum.150061. Epub 2015 Aug 1. Autoantibodies against Endothelin 1 Type A Receptor Are Strong Predictors of Digital Ulcers in Systemic Sclerosis.
Millet A, Martin KR, Bonnefoy F, Saas P, Mocek J, Alkan M, Terrier B, Kerstein A, Tamassia N, Satyanarayanan SK, Ariel A, Ribeil JA, Guillevin L, Cassatella MA, Mueller A, Thieblemont N, Lamprecht P, Mouthon L, Perruche S, Witko-Sarsat V. Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis. J Clin Invest. 2015 Nov 2;125(11):4107-21. doi: 10.1172/JCI78182. Epub 2015 Oct 5.
Humrich JX, von Spee C, Riemekasten G. Stärkung der regulatorischen T-Zellen durch Interleukin-2 Therapie. Drug Res (Stuttg). 2015 Nov;65 Suppl 1:S23. doi: 10.1055/s-0035-1558075. Epub 2015 Nov 4. German. No abstract available.
Hellmich B, Lamprecht P, Moosig F. [Vasculitides].[Article in German]Z Rheumatol. 2015 Dec;74(10):852-3. doi: 10.1007/s00393-015-0013-y.
Hunzelmann N, Riemekasten G, Becker M, Moinzadeh P, Kreuter A, Melchers I, Mueller-Ladner U, Meier F, Worm M, Lee H, Herrgott I, Pfeiffer C, Fierlbeck G, Henes J, Juche A, Zeidler G, Mensing H, Günther C,
Sárdy M, Burkhardt H, Koehm M, Kuhr K, Krieg T, Sunderkötter C. The Predict Study: Low risk for digital ulcer development in Systemic Sclerosis patients with increasing disease duration and lack of topoisomerase-1 antibodies. Br J Dermatol. 2015 Dec 26. [Epub ahead of print]